Pay-for-performance, and its ultimate embodiment, value-based purchasing, have become common in developed world health systems as a method to encourage delivery of better quality and more appropriate care. The effectiveness of these approaches, however, is yet to be clearly demonstrated by the research. (NBER Paper) A new paper from the National Bureau of Economic Research examines the application of these programs to middle and low-income countries. The authors focus on four key issues, what to reward, who to reward, how to reward and identification and avoidance of undesirable and unintended consequences of initiating a pay-for-performance program. They note that many lower income countries have poor health care workforces and that the hope is that pay-for-performance can create rapid improvement. They go on, however, to address concerns about whether the programs are being properly designed in light of the current state of the research on the key issues they raise, and they further discuss the inadequacies of the research in helping to create an optimum design. The paper is a helpful reprise of general issues regarding these programs and a warning about two quickly taking developed country approaches, which may not even be working in those countries, to less-developed nations.
Pay for Performance in Lower Income Countries
By Kevin RocheApril 9, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
For those who would like to read more on the crisis of fake and bad science, read this excellent report from the National Association of Scholars. just click this post.
June 4, 2023
CVS has finalized its $10.6 billion buyout of Oak Street health, which operates primary care centers for Medicare members. People may think CVS is a drug store company, but it...
May 4, 2023
Option Care, a large home health care provider is acquiring Amedisys, another large player in that market, for $3.6 billion, as consolidation ramps up across health care, likely meaning higher...
May 4, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
June 8, 2023
Yet Another Comprehensive Look at Lockdowns
Another major report finds that lockdowns had very little efficacy, in regard to infections or…
June 7, 2023
More and More on Jobs Reports
More BLS machinations around jobs numbers, this time in regard to seasonal adjustments.
June 7, 2023
Me on a Podcast
Your opportunity to see and hear me, courtesy of the Michele Tafoya podcast.